Identification and management of PSP and MSA
Dr Boyd Ghosh speaks to delegates about multiple systems atrophy (MSA) and supranuclear palsy (PSP) which are atypical parkinsonian syndromes that are fairly difficult to diagnose in the early stages. Boyd shows delegates videos of patients so that they can learn to recognise how MSA and PSP are different from Parkinson’s disease. For example patients with PSP do not have Levodopa responsiveness or may be sensitive to light, which is a sign that it not always readily recognised.
[youtube https://www.youtube.com/watch?v=Ms8bJ18UdMs&w=560&h=315]Related articles
Hunter Parkinson's Society Meeting 16
'The things you can't get from the books'
Parkinson's Academy, our original and longest running Academy, houses 22 years of inspirational projects, resources, and evidence for improving outcomes for people with Parkinson's. Led by co-founder and educational director Dr Peter Fletcher, the Academy has a truly collegiate feel and prides itself on delivering 'the things you can't get from books' - a practical learning model which inspires all Neurology Academy courses.